Cochlear Migraine: A Possible Cause of Hearing Loss and Tinnitus
By Jen-Tsung Lai, MD, and Tien-Chen Liu, MD, PhD
Migraine headaches are a common clinical dis- ease with an estimated incidence of 13 percent in the general population. In addition to head- aches, many patients present with ear-related complaints, such as vertigo and dizziness, ear fullness, tinni- tus, and hearing loss, attributed to “atypical” migraines. For example, vestibular migraines, Meniere’s disease, benign par- oxysmal positional vertigo, aural fullness and pain, and even pulsatile tinnitus have been reported to be closely related to migraines (J Neurol 2016;263 (Suppl 1):S82; Laryngoscope 2016;126:163; Otol Neurotol. 2011 Feb;32(2):322; Otol Neurotol. 2016 Mar;37(3):244; Otolaryngol Head Neck Surg. 2018 Jan; 158(1):100). Recently, we described co- chlear migraine (CM), which is characterized by episodic at- tacks of auditory symptoms in patients without vertigo (JAMA Otolaryngol Head Neck Surg. 2018;144(3):185). Our na- tionwide population-based study also demonstrated an asso- ciation of migraines with cochlear disorders (JAMA Otolaryngol Head Neck Surg. 2018;144(8):712). Therefore, we believe this migraine variant may account for hearing loss and tinnitus in some patients.
The exact mechanisms that cause a migraine or variants of a migraine are not clear. Espinosa-Sanchez and Escamez-Lo- pez proposed a mechanism for vestibular migraines, which includes inherited brain excitability sensitization and neuro- genic inflammation that activates the trigeminal vascular reflex (Front Neurol. 2015; 6:12). Increased sensitivity and vasodila- tion of blood vessels in the inner ear (caused by the reflex) result in vestibular dysfunction. In theory, apart from the vesti- bule, we think the same mechanism can be applied to the cochlea. Thus, the cochlea alone can be a possible target for migraine-induced neuroinflammatory effects, and CM patients may present with auditory symptoms, such as hearing loss, tinnitus, and hyperacusis, without involving the balance system.
EXAMINING NOTABLE CASES
Classical presentation of CM is episodic, fluctuated hearing loss without vertigo in migraineurs. Their hearing is variable and hearing loss tends to resolve rather than deteriorate further.
Dr. Lai, left, is the chief of otolar- yngology at Kuang-Tien General Hospital in Taichung, Taiwan. Dr. Liu is a professor of otolaryn- gology and the chief of otology at the National Taiwan Univer- sity Hospital in Taipei, Taiwan.
We present a 39-year-old female patient with a history of sev- eral hemicranias and was diagnosed as having migraines with- out aura based on the diagnostic criteria of the International Headache Society. She complained of sudden hearing loss and tinnitus in her right ear. Mild sensorineural hearing loss was observed at that time and she was treated with oral flu- ranazine, a calcium channel antagonist for migraine prophy- laxis. Her serial audiograms from each visit during a five-year follow-up period are shown in Figure 1. Her hearing loss fluc- tuated and was reversible, and she never experienced vertigo.
In some patients, CM can mimic or be mistaken as idio- pathic sudden sensorineural hearing loss (ISSHL) because the hearing loss is severe enough to reach the diagnostic cri- teria of >30 dB in three contagious frequencies. In fact, mi- graines have been proposed as one etiology for ISSHL in the literature (Otol Neuotol. 2017;38:1411).
We present another case of repeated attacks of ISSHL with good recovery in a migraine patient: a 28-year-old woman with three instances of sudden deafness in her left ear within a six-year period. For the first two episodes (Jan. 18, 2010 and July 21, 2014), oral steroid alone was admin- istered within one week of the attack and hearing loss was
8 The Hearing Journal
Downloaded from https://journals.lww.com/thehearingjournal by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3XD1qjFlDbGKDLUBDIOaaIOeLExdX2jTyfEr68reHua0= on 04/12/2020
final hearing test indicated normal hearing in all tested fre- quencies, except for the 8kHz frequency. Therefore, we sug- gest that when atypical findings are observed in patients with ISSHL, such as repeated attacks (same or opposite ear) with good recovery or hearing fluctuates over time, CM may be considered as a differential diagnosis.
In addition to hearing loss, migraines may also be closely related to acute and chronic tinnitus in some patients. Two studies by our group provided supporting evidence to this linkage. First, in the population-based association study, pa- tients with a history of migraines had a significantly increased chance (adjusted odds ratio: 3.30) of developing acute and chronic tinnitus compared with those with no history (JAMA Otolaryngol Head Neck Surg. 2018). Secondly, we used low- dose hormone replacement therapy to treat tinnitus in a small group of menopausal women. The improvement of their tinni- tus was remarkable and encouraging although the study was uncontrolled (Clin Otolaryngol. 2017 Dec;42(6):1366). The exact mechanism for this treatment is not entirely clear, but we found that these patients all had constant migraines and estrogen deficiency is a common trigger of migraines. The most plausible explanation is that the hormone replacement caused a reduction of migraine-induced tinnitus. Tinnitus may be caused by heterogenic mechanisms, and with this indirect evidence, we think that migraines affecting the cochlea is the etiology of tinnitus for certain patients.
Migraines may target the auditory system alone and cause fluctuations of hearing loss as well as tinnitus in some pa- tients. Diagnosis relies upon awareness of this condition and a longer hearing test follow-up. Once the diagnosis is estab- lished, the otologist can start anti-migraine therapy, and hear- ing loss and tinnitus can be treated.